Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-15

Clinical Trial Update: Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated the combination of tiotropium and olodaterol for improving exercise endurance and reducing lung hyperinflation in patients with chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olodaterol (olodaterol)
  • tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2015-09-15